$51.99 (0%)

Volume: 0

Closed: Dec 02, 2022

Hollow Logo Score: 0.000

ChemoCentryx Stock Forecast

$51.99 (0%)

Volume: 0

Closed: Dec 02, 2022

Score Hollow Logo 0.000

ChemoCentryx Stock Statistics NASDAQ:CCXI

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-08-05 - 2022-12-02 BUY 2.91
2022-08-03 - 2022-08-05 HOLD 109.54
2022-07-08 - 2022-08-03 SELL 0.249
2022-06-17 - 2022-07-08 BUY -5.65
2022-06-16 - 2022-06-17 SELL 6.70

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About ChemoCentryx

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of... CCXI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT